The average one-year price target for Cosmo Pharmaceuticals N.V. (OTCPK:CMOPF) has been revised to $167.38 / share. This is an increase of 48.89% from the prior estimate of $112.41 dated April 1, 2025 ...
The average one-year price target for Cosmo Pharmaceuticals N.V. (SWX:COPN) has been revised to CHF 130,56 / share. This is an increase of 15.32% from the prior estimate of CHF 113,22 dated January 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results